TOTAL VOLUME:

$154.4b

24H VOL:

$290,393,159

24H TRANSACTIONS:

2,984,640,614

OPEN INTEREST:

$1,944,100,805

420,493

Markets across

40,511

events

MATCHED EVENTS:

4,612

PLATFORM COVERAGE:

5

Polymarket:

37%

VS.

Kalshi:

63%

BETA
Dashboards
Tour
All
Sports
Colorado vs Calgary: 1st Period Winner
kalshi

Colorado vs Calgary: 1st Period Winner

Volume:
$10,474

Tie

 - Kalshi

Tie - Kalshi

1W

News

Positive

Negative

Neutral

Hover marker for details

Vol.

·

Resolved Oct 8, 2026

Closed: Oct 8, 9:51 PM EST

kalshi

Kalshi

View
Join Kalshi and score $25 for your first trade.
Outcome
Trade
Chance %
Price
Spread
Liquidity
Volume
24h
7d
Open Interest
Ends in
Result
kalshi

Tie

View
100%
Yes 100¢No 0¢
—
N/A
$1,789
N/A
N/A
$1,343
Settled
Yes
kalshi

Colorado

0%
Yes 0¢No 100¢
—
N/A
$8,657
N/A
N/A
$8,240
Settled
No
kalshi

Calgary

0%
Yes 0¢No 100¢
—
N/A
$28
N/A
N/A
$28
Settled
No
Total markets: 3

Description

This market focuses on determining which team will lead after the first period of an NHL hockey game between Colorado and Calgary. It reflects the competitive dynamics of the early game stages, where initial momentum can significantly influence the match's trajectory.

Kalshi

The market resolves based on which team is leading at the end of the first period of the Colorado vs Calgary NHL game scheduled for October 8, 2026. If Calgary scores more goals than Colorado in the first period, the 'Calgary' market resolves to Yes. Conversely, if Colorado scores more goals than Calgary in the first period, the 'Colorado' market resolves to Yes. If both teams score an equal number of goals, or if neither team scores any goals during the first period, the 'Tie' market resolves to Yes. For any game postponements occurring within 48 hours of the original start time, the market remains active and resolves according to the actual first-period result when the game is played. If the game is cancelled or fails to start within 48 hours of its scheduled time, all markets resolve to a fair price, ensuring equitable treatment for all participants.